share_log

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K:重大事件
美股SEC公告 ·  2024/12/20 22:05

牛牛AI助理已提取核心訊息

Cherry Bekaert LLP resigned as MIRA Pharmaceuticals' independent registered public accounting firm on December 16, 2024. Their reports for fiscal years 2022 and 2023 contained no adverse opinions, except for noting material weaknesses in internal control over financial reporting and the company's ability to continue as a going concern.The company appointed Salberg & Company P.A. as its new independent auditor on December 18, 2024, following the Audit Committee's recommendation and Board approval. Prior to this engagement, there were no consultations between MIRA and Salberg regarding accounting principles, audit opinions, or any reportable events as defined by SEC regulations.
Cherry Bekaert LLP resigned as MIRA Pharmaceuticals' independent registered public accounting firm on December 16, 2024. Their reports for fiscal years 2022 and 2023 contained no adverse opinions, except for noting material weaknesses in internal control over financial reporting and the company's ability to continue as a going concern.The company appointed Salberg & Company P.A. as its new independent auditor on December 18, 2024, following the Audit Committee's recommendation and Board approval. Prior to this engagement, there were no consultations between MIRA and Salberg regarding accounting principles, audit opinions, or any reportable events as defined by SEC regulations.
Cherry Bekaert LLP於2024年12月16日辭去了MIRA Pharmaceuticals的獨立註冊公共會計師職務。他們對於2022和2023財年的報告沒有提出不利意見,但指出在財務報告的內部控制和公司持續經營能力方面存在重大弱點。該公司在2024年12月18日根據審計委員會的建議和董事會的批准,任命Salberg & Company P.A.爲新的獨立核數師。在此聘任之前,MIRA與Salberg之間沒有關於會計原則、審計意見或任何符合SEC法規定義的可報告事件的諮詢。
Cherry Bekaert LLP於2024年12月16日辭去了MIRA Pharmaceuticals的獨立註冊公共會計師職務。他們對於2022和2023財年的報告沒有提出不利意見,但指出在財務報告的內部控制和公司持續經營能力方面存在重大弱點。該公司在2024年12月18日根據審計委員會的建議和董事會的批准,任命Salberg & Company P.A.爲新的獨立核數師。在此聘任之前,MIRA與Salberg之間沒有關於會計原則、審計意見或任何符合SEC法規定義的可報告事件的諮詢。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 297

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。